A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...

Why a Peninsula biotech company is targeting a $345M raise. Hint: It has something to do with an aggressive eye cancer.

The Rutgers professor is one of three physicists headed to Norway to split the $1 million prize after an awards ceremony with ...

(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Jack Schlossberg responded to Madonna’s recent confession that his late uncle John F. Kennedy Jr. was one of the best sexual ...

Industry veterans from Sunrise BioVentures to provide strategic and operational support as the company advances its JUN_01 siRNA cardiometabolism program toward Phase 1 clinical t ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

This Peninsula company's plans to go public face a new hurdle.

“You’ve been sick for over two decades,” my husband said one night. “What you’ve experienced has been incredibly traumatic, ...

CEBU’s cultural scene might be getting a major revival this coming August. Governor Pamela Baricuatro has hinted at bringing ...